The General Pharmaceutical Council (GPhC) will judge how compliant pharmacies are with upcoming European anti-counterfeiting measures during premises inspections, it has announced.
Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist
If a pharmacy is found to not meet the requirements of the Falsified Medicines Directive the GPhC will enforce its regulatory powers, such as improvement action plans, to ensure that the pharmacy becomes compliant, it revealed on Friday (18 January).
The regulator said it is working with the UK’s medicines watchdog the Medicines and Healthcare products Regulatory Agency (MHRA) to enforce the directive, which comes into effect on 9 February
Related Article: ‘Streamlined’ DMS claims process to launch in July
The MHRA will be responsible for instigating any action enforcing FMD, including issuing enforcement notices or instigating criminal proceedings ‘for the most serious, persistent breaches’.
Related Article: RPS new director for England will build a ‘vibrant future’ for pharmacy
The two bodies will share information if necessary to ensure that pharmacies meet FMD requirements, the GPhC said.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.